News

The event is scheduled for Tuesday, May 16, at the Le Meridien Hotel in Cambridge.

The two companies will combine digital platforms and health record systems to provide data on patient disease management.

The AI program can detect flags for suspected abdominal aortic aneurysms.

The platforms are designed to improve patient engagement and adherence.

Stanford Biodesign is a training platform for university students that is already supported by multiple industry leaders.

The new platform allows patients to access personalized cancer care.

New interactive tool, other resources help use regulatory strategy to drive successful business strategy for digital medical product development

Kaia Back Pain, a digital therapy for the treatment of non-specific acute, subacute and recurrent back pain, has been permanently added to the Directory of Digital Health Applications (DiGA)

US tops market, followed by China, Canada and Germany

Next-generation immersive mental health technology leverages virtual reality

Fiscal year 2024 budget includes improvements to medical device supply and shortage issues that negatively impact patients

The new API aims to collect more accurate information by utilizing techniques designed to avoid altering patient behavior.

COPD digital app can now be prescribed by medical providers in Germany and will be covered by statutory health insurance.

Based on a broad portfolio of treatments by Novartis across many chronic diseases, the partnership will be taking a strategic approach to prioritize those diseases which are characterized by high levels of unmet patient needs.

ObvioHealth's API provides a tight integration between the digital therapeutic and the ObvioGo platform, providing data that correlates efficacy with adherence to the DTx.

Techquity for Health Coalition hopes to assimilate health equity considerations into healthcare technology innovation and data practices across the industry.

This newly created position is within the Office of Strategic Partnerships and Technology Innovation in the FDA's Center for Devices and Radiological Health (CDRH).

New agreement expands companion diagnostics to build on personalized healthcare commitment.

SCOPE session discusses key challenges of evaluating potential providers.

New offering includes a DCT platform bundled with site and trial execution services for the DTx market.

Software allows sponsors of diagnostic studies to accelerate enrollment and launch their trials more quickly, as the sole execution partner.

ResearchAndMarkets.com releases "Digital Therapeutics: A New Age Medicine"

CB Insights ranks 150 most promising digital health startups in the world.

Avenda Health's iQuest combines existing patient-specific diagnostic information and deep-learning algorithms.

IRIS Registry initiative to help advance data-driven clinical research and care.

RelieVRx enables Veterans a non-pharmacological, noninvasive treatment option.